Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177060 · ClinicalTrials.gov registry record · Phase 1
Topical Hydromorphone for Wound Healing
A Phase 1 study, sponsored by Hordinsky, Maria K., MD.
- Terminated
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT00177060: Clinical Trial Phase 1 study, sponsored by Hordinsky, Maria K., MD.
NCT00177060 is a Phase 1 study that was terminated before completion, run by Hordinsky, Maria K., MD. The registered enrollment target is 50 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00177060, a Phase 1 study, was terminated before completion, sponsored by Hordinsky, Maria K., MD.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The hypothesis is that topical opioids will hasten wound healing in humans.
Interventions
- DRUG hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2003-10 |
| Est. Completion | 2007-05 |
| Phase | Phase 1 |
Why NCT00177060 stopped before completion
NCT00177060 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% lower).
The record links to 0 conditions, and to 1 intervention - of which hydromorphone is the first listed.
NCT00177060 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00177060 about?
NCT00177060 is a clinical study titled "Topical Hydromorphone for Wound Healing". The hypothesis is that topical opioids will hasten wound healing in humans.
What is the current status of trial NCT00177060?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2003-10. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00177060?
The interventions under investigation include: hydromorphone (DRUG).
Who is sponsoring clinical trial NCT00177060?
This trial is sponsored by Hordinsky, Maria K., MD, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00177060's enrollment target sits among peer trials
50 973rd of 2000 higher than 984 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia